Point72 Asset Management, L.P. 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:15 pm Sale | 2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Point72 Asset Management, L.P. | 30,702 0.100% | -2,037,172 (-98.52%) | Filing |
| 2022-06-22 4:14 pm Purchase | 2022-06-21 | 13G | Fulcrum Therapeutics, Inc. FULC | Point72 Asset Management, L.P. | 2,067,874 5.100% | 729,206 (+54.47%) | Filing |
| 2021-02-16 3:22 pm Sale | 2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Point72 Asset Management, L.P. | 1,338,668 4.900% | -43,340 (-3.14%) | Filing |